dnai – Scalper1

Biotechs ProNAi Therapeutics, Chiasma, Jump In IPOs

ProNAi Therapeutics (DNAI) rose strongly as it made its initial public offering Thursday, raising $138 million. Another biotech IPO with a strong showing Thursday was Chiasma (CHMA), which priced above its estimated range and raised $102 million. ProNAi offered 8.1 million shares at 17, up from previous plans to sell 6.7 million shares. ProNAi stock was up 82%, near 31, in midday trading on the stock market today. Vancouver-based ProNAi is a

3 IPOs That Are Getting Strong Investor Attention

With strong investor demand for shares, ProNAi Therapeutics (DNAI) raised the expected price of its initial public offering, which is scheduled to price after the close Wednesday. ProNAi is among three of the eight IPOs out this week that are receiving strong investor interest. The others are discount retailer Ollie’s Bargain Outlet (OLLI) and cybersecurity firm Rapid7 (RPD). ProNAi is described as “a clinical-stage oncology company pioneering a